Intercept Pharmaceuticals Inc (ICPT):企業の財務・戦略的SWOT分析

◆英語タイトル:Intercept Pharmaceuticals Inc (ICPT) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1323
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:53
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Intercept Pharmaceuticals Inc (ICPT) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Intercept Pharmaceuticals Inc (Intercept) is a biopharmaceutical company that researches, develops, and commercializes treatments for non-viral, progressive liver diseases. It develops products using proprietary bile acid chemistry. The company’s lead product candidate, obeticholic acid (OCA), is a bile acid analog and first-in-class agonist of the farnesoid X receptor. The company is advancing OCA for the treatment of various other liver diseases. It is also advancing INT-767 for the treatment of fibrosis; and INT-787 with anti-inflammatory and anti-fibrotic effects. Intercept is headquartered in New York, the US.

Intercept Pharmaceuticals Inc Key Recent Developments

Mar 26,2020: Intercept Pharmaceuticals Provides Regulatory and Business Update
Feb 25,2020: Intercept Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results, Issues 2020 Operating Expense Guidance and Provides Business Update
Jan 17,2020: FDA Accepts Intercept’s NDA for OCA for the Treatment of Liver Fibrosis Due to NASH and Grants Priority Review
Dec 02,2019: Intercept Pharmaceuticals appoints Jason Campagna as Chief Medical Officer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Intercept Pharmaceuticals Inc – Key Facts
Intercept Pharmaceuticals Inc – Key Employees
Intercept Pharmaceuticals Inc – Key Employee Biographies
Intercept Pharmaceuticals Inc – Major Products and Services
Intercept Pharmaceuticals Inc – History
Intercept Pharmaceuticals Inc – Company Statement
Intercept Pharmaceuticals Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Intercept Pharmaceuticals Inc – Business Description
R&D Overview
Intercept Pharmaceuticals Inc – Corporate Strategy
Intercept Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Intercept Pharmaceuticals Inc – Strengths
Intercept Pharmaceuticals Inc – Weaknesses
Intercept Pharmaceuticals Inc – Opportunities
Intercept Pharmaceuticals Inc – Threats
Intercept Pharmaceuticals Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Intercept Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Intercept Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Intercept Pharmaceuticals Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 26, 2020: Intercept Pharmaceuticals Provides Regulatory and Business Update
Feb 25, 2020: Intercept Pharmaceuticals reports fourth quarter and full year 2019 financial results, issues 2020 operating expense guidance and provides business update
Dec 02, 2019: Intercept Pharmaceuticals appoints Jason Campagna as Chief Medical Officer
Nov 05, 2019: Intercept Pharmaceuticals reports third quarter 2019 financial results and provides business update
Sep 11, 2019: Intercept launches, an online educational resource for people with advanced fibrosis due to NASH
Aug 07, 2019: Intercept Pharmaceuticals reports second quarter 2019 financial results and provides business update
May 08, 2019: Intercept Pharmaceuticals reports first quarter 2019 financial results and provides business update
Feb 28, 2019: Intercept Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results, Issues 2019 Financial Guidance and Provides Business Update
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Intercept Pharmaceuticals Inc, Key Facts
Intercept Pharmaceuticals Inc, Key Employees
Intercept Pharmaceuticals Inc, Key Employee Biographies
Intercept Pharmaceuticals Inc, Major Products and Services
Intercept Pharmaceuticals Inc, History
Intercept Pharmaceuticals Inc, Other Locations
Intercept Pharmaceuticals Inc, Subsidiaries
Intercept Pharmaceuticals Inc, Key Competitors
Intercept Pharmaceuticals Inc, Ratios based on current share price
Intercept Pharmaceuticals Inc, Annual Ratios
Intercept Pharmaceuticals Inc, Annual Ratios (Cont...1)
Intercept Pharmaceuticals Inc, Interim Ratios
Intercept Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Intercept Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Intercept Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Intercept Pharmaceuticals Inc, Performance Chart (2015 - 2019)
Intercept Pharmaceuticals Inc, Ratio Charts
Intercept Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Intercept Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Intercept Pharmaceuticals Inc (ICPT):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Electrical Geodesics Inc:企業の製品パイプライン分析2018
    Summary Electrical Geodesics Inc (EGI) is a medical device company that designs, develops and commercializes non-invasive neuro diagnostic products used to monitor and interpret brain activity. The company offers clinical products such as geodesic EEG system 400 series, spike detection software, geo …
  • Fugro GeoServices Ltd:企業の戦略的SWOT分析
    Fugro GeoServices Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Pulsion Medical Systems SE (PUS):医療機器:M&Aディール及び事業提携情報
    Summary Pulsion Medical Systems SE (Pulsion Medical Systems), formerly Pulsion Medical Systems AG, a subsidiary of Getinge AB, is a medical device company that manufactures and develops critical care systems and monitors. The company’s products include ProAQT sensor, PiCCO catheter, CeVOX module, Pi …
  • BE Semiconductor Industries NV (BESI):企業の財務・戦略的SWOT分析
    BE Semiconductor Industries NV (BESI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Maersk Line AS:企業の戦略的SWOT分析
    Maersk Line AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Boardwalk Pipeline Partners LP:企業の戦略・SWOT・財務情報
    Boardwalk Pipeline Partners LP - Strategy, SWOT and Corporate Finance Report Summary Boardwalk Pipeline Partners LP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Bayshore Petroleum Corp (BSH):石油・ガス:M&Aディール及び事業提携情報
    Summary Bayshore Petroleum Corp (Bayshore Petroleum) is an oil and gas company that explores, produces, and develops natural gas and petroleum. The company develops conventional and unconventional oil and gas prospects in North America and across the world. Its CCC technology provides heavy oil and …
  • Vermilion Energy Inc (VET):企業の財務・戦略的SWOT分析
    Summary Vermilion Energy Inc (Vermilion) is an oil and gas company that offers exploration and production services. The company is an oil and gas producer in Alberta. It provides production programs focusing on acquisition, exploration, development and optimization in North America, Europe and Austr …
  • Huesker Synthetic Gmbh:企業の戦略・SWOT・財務分析
    Huesker Synthetic Gmbh - Strategy, SWOT and Corporate Finance Report Summary Huesker Synthetic Gmbh - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Dialog Group Berhad (DIALOG):企業の財務・戦略的SWOT分析
    Dialog Group Berhad (DIALOG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • The Royal Bank of Scotland Group Plc:企業のM&A・事業提携・投資動向
    The Royal Bank of Scotland Group Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Royal Bank of Scotland Group Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports …
  • Sunnova Energy Corporation:電力:M&Aディール及び事業提携情報
    Summary Sunnova Energy Corporation (Sunnova Energy) is engaged in providing solar power services to homeowners. The company is involved in installing and generating power. It offers solar service agreements such as EZ Pay PPA, PPA, EZ own plan, and solar lease plan. In addition, the company offers s …
  • American Electric Power Company, Inc. (AEP)-エネルギー分野:企業M&A・提携分析
    Summary American Electric Power Company, Inc. (AEP) is a holding company that carries out the generation, transmission and distribution of electricity through its subsidiaries. The company generates electricity through various sources of energy such as coal and lignite, natural gas, nuclear, and hyd …
  • InsuLine Medical Ltd (INSL)-医療機器分野:企業M&A・提携分析
    Summary InsuLine Medical Ltd (InsuLine Medical) is a medical device company that develops, manufactures and markets device which enables patients on intensive insulin therapy. The company’s products include InsuPad and InsuPatch. Its InsuPad is a patch for syringes and insulin pens; and InsuPatch is …
  • SimCorp AS (SIM):企業の財務・戦略的SWOT分析
    SimCorp AS (SIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Cellular Biomedicine Group Inc (CBMG):製薬・医療:M&Aディール及び事業提携情報
    Summary Cellular Biomedicine Group Inc (CBMG) is a clinical stage biopharmaceutical firm that develops biomedicine, immunotherapy products for cancer and stem cell therapies to address patient specific medical conditions. The firm’s products comprise clinical treatment protocols for the treatment of …
  • VP Bank AG (VPBN):企業の財務・戦略的SWOT分析
    Summary VP Bank AG (VP Bank) is a financial service provider that offers banking services, asset management, and portfolio advisory services to institutional and private investors. The company provides a wide variety of house solutions, third-party financial products through a network of strategical …
  • Kirby Corporation:企業の戦略・SWOT・財務情報
    Kirby Corporation - Strategy, SWOT and Corporate Finance Report Summary Kirby Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Forrester Research, Inc.:企業の戦略・SWOT・財務分析
    Forrester Research, Inc. - Strategy, SWOT and Corporate Finance Report Summary Forrester Research, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Martin Mathew & Co. Ltd.:企業の戦略・SWOT・財務情報
    Martin Mathew & Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Martin Mathew & Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆